Glycoprotein IIb/IIIa Receptor Antagonists Inhibit the Development of Platelet Procoagulant Activity
- 1 June 1998
- journal article
- Published by Elsevier in Thrombosis Research
- Vol. 90 (6) , 247-258
- https://doi.org/10.1016/s0049-3848(98)00029-2
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Molecular Cloning of Human Plasma Membrane Phospholipid ScramblaseJournal of Biological Chemistry, 1997
- Effector Cell Protease Receptor-1, a Platelet Activation-dependent Membrane Protein, Regulates Prothrombinase-catalyzed Thrombin GenerationJournal of Biological Chemistry, 1997
- Effect of platelet glycoprotein IIb/IIIa integrin blockade on activated clotting time during percutaneous transluminal coronary angioplasty or directional atherectomy (the EPIC trial)The American Journal of Cardiology, 1995
- New Antiplatelet Agents: Platelet GPIIb/llla AntagonistsThrombosis and Haemostasis, 1995
- Use of a Monoclonal Antibody Directed against the Platelet Glycoprotein IIb/IIIa Receptor in High-Risk Coronary AngioplastyNew England Journal of Medicine, 1994
- Phospholipids in animal eukaryotic membranes: transverse asymmetry and movementBiochemical Journal, 1993
- Mechanisms Involved in Platelet Procoagulant ResponsePublished by Springer Nature ,1993
- Transbilayer movement of phospholipids in red cell and platelet membranesBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1991
- The response of human platelets to activated components of the complement systemImmunology Today, 1991
- Changes in membrane phospholipid distribution during platelet activationBiochimica et Biophysica Acta (BBA) - Biomembranes, 1983